SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $96.24 | 52-week high | $105.47 |
| Prev. close | $94.30 | 52-week low | $71.99 |
| Day low | $94.16 | Volume | 9,684,600 |
| Day high | $96.61 | Avg. volume | 9,506,914 |
| 50-day MA | $98.44 | Dividend yield | 0.15% |
| 200-day MA | $95.05 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 6.77B |
| Net Asset Value (NAV) | $94.28 |
| Options? | Yes |
| Total Holdings | 148 |
XBI Top Holdings
| Symbol | Company | % of Total |
| NTRA | NATERA INC | 3.53% |
| INCY | INCYTE CORP | 2.97% |
| UTHR | UNITED THERAPEUTICS CORP | 2.86% |
| GILD | GILEAD SCIENCES INC | 2.85% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2.68% |
| INSM | INSMED INC | 2.59% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 2.5% |
| VRTX | VERTEX PHARMACEUTICALS INC | 2.47% |
| SRPT | SAREPTA THERAPEUTICS INC | 2.37% |
| AMGN | AMGEN INC | 2.3% |
XBI Price Returns
| 1-mo | -1.04% |
| 3-mo | -5.18% |
| 6-mo | N/A |
| 1-year | 30.86% |
| 3-year | -19.71% |
| 5-year | 5.15% |
| YTD | 7.93% |
| 2023 | 7.60% |
| 2022 | -25.87% |
| 2021 | -20.45% |
| 2020 | 48.33% |
| 2019 | 32.56% |
XBI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||